1. An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab. (1st June 2016) Authors: Wyant, Tim; Fedyk, Eric; Abhyankar, Brihad Journal: Journal of Crohn's and colitis Issue: Volume 10:Number 12(2016:Dec.) Page Start: 1437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corticosteroid Dose Reduction in Ulcerative Colitis Patients Treated With Vedolizumab During the GEMINI 1 Trial: 1859. (October 2015) Authors: Loftus, Edward V.; Siegel, Corey A.; Panaccione, Remo; Sandborn, William J.; Smyth, Michael DL.; Green, Alexandra; Xu, Jing; Abhyankar, Brihad Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corticosteroid Dose Reduction With Vedolizumab Treatment of Crohn's Disease During the GEMINI 2 Trial: 1857. (October 2015) Authors: Loftus, Edward V.; Siegel, Corey A.; Panaccione, Remo; Sandborn, William J.; Smyth, Michael DL.; Green, Alexandra; Xu, Jing; Abhyankar, Brihad Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Defining Remission Using Patient‐reported Outcome Components of the Crohn's Disease Activity Index: Post‐hoc Analyses of Vedolizumab Data from the GEMINI 2 Study: 1865. (October 2015) Authors: Sandborn, William J.; Vermeire, Séverine; Sands, Bruce E.; Feagan, Brian; Shetzline, Michael; Xu, Jing; Mody, Reema; Parikh, Asit; Abhyankar, Brihad Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme. (11th March 2020) Authors: Sandborn, William J; Nguyen, Deanna D; Beattie, David T; Brassil, Patrick; Krey, Whitney; Woo, Jacky; Situ, Eva; Sana, Reuben; Sandvik, Erik; Pulido-Rios, M Teresa; Bhandari, Raj; Leighton, Jonathan A; Ganeshappa, Ravi; Boyle, David L; Abhyankar, Brihad; Kleinschek, Melanie A; Graham, Richard A; ... Journal: Journal of Crohn's and colitis Issue: Volume 14:Number 9(2020) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Early Clinical Response and Remission With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY: 716. (October 2019) Authors: Danese, Silvio; Loftus, Edward V.; Colombel, Jean‐Frédéric; Peyrin‐Biroulet, Laurent; Abhyankar, Brihad; Chen, Jingjing; Rogers, Raquel; Lirio, Richard A.; Bornstein, Jeffrey D.; Schreiber, Stefan; Sands, Bruce E. Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and Safety of Vedolizumab With Advancing Age in Patients With Crohn's Disease: Results From the GEMINI 2 Study: 1860. (October 2015) Authors: Yajnik, Vijay; Khan, Nabeel; Dubinsky, Marla; Axler, Jeffrey; Green, Alexandra; Abhyankar, Brihad; Lasch, Karen Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of Vedolizumab Maintenance Therapy With and Without Continued Immunosuppressant Use in GEMINI 1 and GEMINI 2: 1862. (October 2015) Authors: Feagan, Brian; Siegel, Corey A.; Melmed, Gil; Isaacs, Kim; Lasch, Karen; Rosario, Maria; Green, Alexandra; Abhyankar, Brihad Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Histologic Improvement With Vedolizumab vs. Adalimumab in Ulcerative Colitis: Results From VARSITY: 757. (October 2019) Authors: Peyrin‐Biroulet, Laurent; Colombel, Jean‐Frédéric; Loftus, Edward V.; Danese, Silvio; Abhyankar, Brihad; Chen, Jingjing; Rogers, Raquel; Lirio, Richard A.; Bornstein, Jeffrey D.; Sands, Bruce E.; Schreiber, Stefan Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP34 VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis. (22nd February 2019) Authors: Schreiber, Stefan; Peyrin-Biroulet, Laurent; Loftus, Edward V; Danese, Silvio; Colombel, Jean-Frederic; Abhyankar, Brihad; Chen, Jingjing; Rogers, Raquel; Lirio, Richard A; Bornstein, Jeffrey D; Sands, Bruce E Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗